Legal25 Aug 2026, 09:20 pm
AstraZeneca Pharma India: Delhi HC Stays NPPA Demand Notice
AI Summary
AstraZeneca Pharma India Ltd has received a stay from the Hon'ble High Court of Delhi on a demand notice issued by the National Pharmaceutical Pricing Authority (NPPA). The NPPA had alleged overcharging for Betaloc-50 (Metoprolol 50 mg tablets) between June and July 2016. The High Court has stayed the operation of the demand notice until February 10, 2027, provided the company deposits 15% of the demanded amount with the Registrar General of the Court. This action is in response to the company challenging the NPPA's demand for recovery of alleged overcharged amounts.
Key Highlights
- Delhi High Court stays NPPA demand notice for alleged overcharging.
- Stay is effective until February 10, 2027, subject to deposit.
- Company challenged NPPA's demand regarding Betaloc-50 pricing.
- 15% of the demand amount must be deposited with the Court.
Price Impact
More from ASTRAZEN